Kazimi A J

Chairman and CEO, Director, 10% OwnerCUMBERLAND PHARMACEUTICALS INC (CPIX) · full profile →Form 4 · filed Jan 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
22
22 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2025Small acquisition(L)7$3.91$275.7M
Dec 30, 2025Small acquisition(L)8$3.94$325.7M
Dec 29, 2025Small acquisition(L)8$4.01$325.7M
Dec 26, 2025Small acquisition(L)8$4.21$345.7M
Dec 24, 2025Small acquisition(L)8$4.26$345.7M
Dec 23, 2025Small acquisition(L)8$4.13$335.7M
Dec 22, 2025Small acquisition(L)7$4.32$305.7M
Dec 19, 2025Small acquisition(L)8$4.19$345.7M
Dec 18, 2025Small acquisition(L)10$4.19$425.7M
Dec 17, 2025Small acquisition(L)10$3.65$375.7M
Dec 16, 2025Small acquisition(L)14$3.27$465.7M
Dec 15, 2025Small acquisition(L)14$2.82$395.7M
Dec 12, 2025Small acquisition(L)14$2.50$355.7M
Dec 11, 2025Small acquisition(L)14$2.56$365.7M
Dec 10, 2025Small acquisition(L)14$2.60$365.7M
Dec 9, 2025Small acquisition(L)14$2.32$325.7M
Dec 8, 2025Small acquisition(L)14$2.40$345.7M
Dec 5, 2025Small acquisition(L)18$2.34$425.7M
Dec 4, 2025Small acquisition(L)18$2.27$415.7M
Dec 3, 2025Small acquisition(L)18$2.25$415.7M
Dec 2, 2025Small acquisition(L)18$2.24$405.7M
Dec 1, 2025Small acquisition(L)18$2.36$425.7M

Transaction Codes

L
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001087294-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: